Charles Schwab’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,061,176
| Closed | -$195M | – | 3594 |
|
|
2021
Q2 | $195M | Buy |
1,061,176
+27,593
| +3% | +$4.74M | 0.06% | 271 |
|
|
2021
Q1 | $158M | Sell |
1,033,583
-53,350
| -5% | -$8.25M | 0.06% | 297 |
|
|
2020
Q4 | $170M | Sell |
1,086,933
-229,255
| -17% | -$29.5M | 0.07% | 261 |
|
|
2020
Q3 | $151M | Sell |
1,316,188
-111,051
| -8% | -$12M | 0.07% | 250 |
|
|
2020
Q2 | $160M | Buy |
1,427,239
+63,205
| +5% | +$6.71M | 0.08% | 233 |
|
|
2020
Q1 | $122M | Sell |
1,364,034
-38,250
| -3% | -$3.75M | 0.07% | 251 |
|
|
2019
Q4 | $152M | Buy |
1,402,284
+115,764
| +9% | +$12.4M | 0.08% | 224 |
|
|
2019
Q3 | $126M | Buy |
1,286,520
+33,791
| +3% | +$3.81M | 0.07% | 255 |
|
|
2019
Q2 | $164M | Buy |
1,252,729
+59,132
| +5% | +$7.62M | 0.1% | 192 |
|
|
2019
Q1 | $161M | Buy |
1,193,597
+242,174
| +25% | +$30.1M | 0.1% | 181 |
|
|
2018
Q4 | $92.6M | Buy |
951,423
+71,266
| +8% | +$8.42M | 0.07% | 252 |
|
|
2018
Q3 | $122M | Buy |
880,157
+3,551
| +0.4% | +$445K | 0.08% | 224 |
|
|
2018
Q2 | $109M | Sell |
876,606
-44,119
| -5% | -$5.16M | 0.08% | 232 |
|
|
2018
Q1 | $103M | Buy |
920,725
+13,920
| +2% | +$1.66M | 0.08% | 243 |
|
|
2017
Q4 | $108M | Buy |
906,805
+56,472
| +7% | +$6.88M | 0.09% | 218 |
|
|
2017
Q3 | $119M | Buy |
850,333
+54,761
| +7% | +$7.44M | 0.1% | 184 |
|
|
2017
Q2 | $96.8M | Buy |
795,572
+97,659
| +14% | +$11.4M | 0.09% | 217 |
|
|
2017
Q1 | $84.6M | Buy |
697,913
+57,455
| +9% | +$7.41M | 0.08% | 229 |
|
|
2016
Q4 | $78.4M | Buy |
640,458
+12,731
| +2% | +$1.56M | 0.09% | 227 |
|
|
2016
Q3 | $76.9M | Buy |
627,727
+14,600
| +2% | +$1.88M | 0.09% | 227 |
|
|
2016
Q2 | $71.6M | Buy |
613,127
+11,923
| +2% | +$1.69M | 0.09% | 230 |
|
|
2016
Q1 | $83.7M | Buy |
601,204
+22,758
| +4% | +$3.34M | 0.11% | 173 |
|
|
2015
Q4 | $110M | Buy |
578,446
+29,410
| +5% | +$5.14M | 0.15% | 130 |
|
|
2015
Q3 | $85.9M | Sell |
549,036
-11,392
| -2% | -$2.08M | 0.13% | 155 |
|
|
2015
Q2 | $101M | Buy |
560,428
+81,607
| +17% | +$14.1M | 0.14% | 141 |
|
|
2015
Q1 | $83M | Buy |
478,821
+30,105
| +7% | +$5.45M | 0.12% | 173 |
|
|
2014
Q4 | $83M | Sell |
448,716
-9,102
| -2% | -$1.69M | 0.12% | 165 |
|
|
2014
Q3 | $75.9M | Buy |
457,818
+9,511
| +2% | +$1.56M | 0.12% | 162 |
|
|
2014
Q2 | $70M | Buy |
448,307
+15,982
| +4% | +$2.52M | 0.12% | 176 |
|
|
2014
Q1 | $65.8M | Buy |
432,325
+42,841
| +11% | +$6.81M | 0.12% | 176 |
|
|
2013
Q4 | $51.8M | Buy |
389,484
+17,105
| +5% | +$2.05M | 0.1% | 201 |
|
|
2013
Q3 | $43.7M | Buy |
372,379
+18,285
| +5% | +$2.01M | 0.09% | 227 |
|
|
2013
Q2 | $33.9M | Buy |
+354,094
| New | +$34.1M | 0.08% | 249 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM